PharVision Advisers’s Aeva Technologies AEVA Stock Holding History

PharVision Advisers’s Portfolio AEVA Stock Details AEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-10,662	Closed	-$142K	–	109
2025 Q4	$142K	Buy	+10,662	New	+$152K	0.07%	621

Other funds holding AEVA

Sylebra Capital Palo Alto, California $774M AUM 56.69% 1-Year Est. Return

CPX

Canaan Partners XI Menlo Park, California $76.1M AUM 638.59% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AMH

Apollo Management Holdings New York $7.6B AUM 23.97% 1-Year Est. Return

Parkwood LLC Cleveland, Ohio $1.13B AUM 32.89% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Think Investments San Francisco, California $762M AUM 33.1% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

DGM

Delta Global Management New York $1.22B AUM 34.86% 1-Year Est. Return

PharVision Advisers's AEVA Position: Q1 2026 in Review

PharVision Advisers sold out of Aeva Technologies (AEVA) in Q1 2026, closing a stake of 10,662 shares — an estimated $142K sold.

PharVision Advisers first reported a position in AEVA in Q4 2025 and held it in 1 quarter. The position peaked at $142K in Q4 2025. 154 funds tracked by Wall St. Rank hold AEVA as of Q1 2026.

PharVision Advisers reported no remaining Aeva Technologies position as of Q1 2026 after selling out during the quarter.
PharVision Advisers sold 10,662 Aeva Technologies shares in Q1 2026, an estimated $142K.
PharVision Advisers first reported a position in Aeva Technologies in Q4 2025 and held it in 1 quarter.
PharVision Advisers's Aeva Technologies position peaked at $142K in Q4 2025.
154 funds tracked by Wall St. Rank held Aeva Technologies as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.